Novele
PrivateLast Round
Series A
Sep 30, 2026
Total Funding Raised
$17.27M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Novele operates in Energy & Sustainability and is based in New York City, New York. Its latest recorded funding round was a Series A round in September 2026.
Novele is a cleantech company that develops an autonomous energy management platform and distributed energy storage hardware for commercial buildings.
Sector
Energy & Sustainability
Verticals
Energy Storage, Energy Management, Smart Grid, Facility Management
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novele Comparables
Compare Novele with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Urban Electric Power | 78% | |
| Viridi Parente | 77% | |
| Stem | 68% |
For institutional investors. Book with your work email.
Novele Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 30, 2026 | ||||
| Strategic | Jan 31, 2025 | ||||
| Accelerator | Mar 27, 2023 | ||||
| Accelerator | Jan 31, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novele Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GINCO Investments | Accelerator |
| Locke Health | Series A |
| Techstars | Accelerator |
| URBAN-X | Accelerator |
| Arup Ventures | Series A |
| Jerusalem Venture Partners | Accelerator |
| boisei labs | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2026
Raised $17M led by boisei labs
- Jul 27, 2026
Monthly visitors increased 33% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 5, 2026
Novele raises a $17M Series A led by Boisei Labs, with participation from Locke Health, Arup Ventures, Barton Malow, and several commercial real estate owners and operators, to expand its services nationally on Sep 30th '26.
For institutional investors. Book with your work email.
Novele Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novele's valuation, stock price, and market status.
Is Novele a public or private company?
Novele is a private company.
What is the current stock price of Novele?
Novele is a private company, so its shares have no public market price. Caplight tracks Novele's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novele worth (valuation)?
Valuation information for Novele is not publicly available.
Can I buy Novele stock?
Novele shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novele's last funding round?
Novele's most recent funding round was Series A on September 30, 2026.
Who are the main investors in Novele?
Key investors in Novele include boisei labs.
Will Novele IPO soon?
No public IPO plans have been announced for Novele.
How can I track Novele secondary market activity?
Caplight tracks bids, offers, and trades in Novele's shares on secondary markets.